The innate immune response to RSV: Advances in our understanding of critical viral and host factors

Vaccine

Volumn 35, Issue 3, 2017, Pages 481-488

  Sun, Yan ^a   López, Carolina B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Defective viral genomes; Innate immunity; NS1 and NS2 degradasome; Respiratory syncytial virus; Viral recognition

Indexed keywords

HOST FACTOR; INTERFERON; INTERFERON III; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS RNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRESS; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INNATE IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; HOST PATHOGEN INTERACTION; IMMUNOLOGY;

HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84995780936     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.09.030     Document Type: Article

References (100)

1. [1] Miller, E.K., Gebretsadik, T., Carroll, K.N., Dupont, W.D., Mohamed, Y.A., Morin, L.L., et al. Viral etiologies of infant bronchiolitis, croup and upper respiratory illness during 4 consecutive years. Pediatr Infect Dis J 32 (2013), 950–955.
2. [2] Pilie, P., Werbel, W.A., Riddell, Jt, Shu, X., Schaubel, D., Gregg, K.S., Adult patients with respiratory syncytial virus infection: impact of solid organ and hematopoietic stem cell transplantation on outcomes. Transplant Inf Dis: Off J Transplant Soc 17 (2015), 551–557.
3. [3] Fleming, D.M., Taylor, R.J., Lustig, R.L., Schuck-Paim, C., Haguinet, F., Webb, D.J., et al. Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis, 15, 2015, 443.
4. [4] Seemungal, T., Harper-Owen, R., Bhowmik, A., Moric, I., Sanderson, G., Message, S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001), 1618–1623.
5. [5] Khushalani, N.I., Bakri, F.G., Wentling, D., Brown, K., Mohr, A., Anderson, B., et al. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review. Bone Marrow Transplant 27 (2001), 1071–1073.
6. [6] Message, S.D., Johnston, S.L., Viruses in asthma. Br Med Bull 61 (2002), 29–43.
7. [7] Sigurs, N., Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir Res 3 (2002), S8–S14.
8. [8] Chanock, R., Roizman, B., Myers, R., Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg 66 (1957), 281–290.
9. [9] Collins, P.L., Graham, B.S., Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol 82 (2008), 2040–2055.
10. [10] Yamaguchi, M., Sano, Y., Dapat, I.C., Saito, R., Suzuki, Y., Kumaki, A., et al. High frequency of repeated infections due to emerging genotypes of human respiratory syncytial viruses among children during eight successive epidemic seasons in Japan. J Clin Microbiol 49 (2011), 1034–1040.
11. [11] Hall, C.B., Long, C.E., Schnabel, K.C., Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis 33 (2001), 792–796.
12. [12] Sun, Y., Jain, D., Koziol-White, C.J., Genoyer, E., Gilbert, M., Tapia, K., et al. Immunostimulatory defective viral genomes from respiratory syncytial virus promote a strong innate antiviral response during infection in mice and humans. PLoS Pathog, 11, 2015, e1005122.
13. [13] Lopez, C.B., Defective viral genomes: critical danger signals of viral infections. J Virol 88 (2014), 8720–8723.
14. [14] Mukherjee, S., Lukacs, N.W., Innate immune responses to respiratory syncytial virus infection. Curr Top Microbiol Immunol 372 (2013), 139–154.
15. [15] Kim, T.H., Lee, H.K., Innate immune recognition of respiratory syncytial virus infection. BMB Rep 47 (2014), 184–191.
16. [16] Marr, N., Turvey, S.E., Grandvaux, N., Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective. Trends Microbiol 21 (2013), 568–574.
17. [17] Yoneyama, M., Onomoto, K., Jogi, M., Akaboshi, T., Fujita, T., Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol 32 (2015), 48–53.
18. [18] Bhoj, V.G., Sun, Q., Bhoj, E.J., Somers, C., Chen, X., Torres, J.P., et al. MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus. Proc Natl Acad Sci USA 105 (2008), 14046–14051.
19. [19] Demoor, T., Petersen, B.C., Morris, S., Mukherjee, S., Ptaschinski, C., De Almeida Nagata, D.E., et al. IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus. J Immunol 189 (2012), 5942–5953.
20. [20] Scagnolari, C., Midulla, F., Pierangeli, A., Moretti, C., Bonci, E., Berardi, R., et al. Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 16 (2009), 816–823.
21. [21] Liu, P., Li, K., Garofalo, R.P., Brasier, A.R., Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway. J Biol Chem 283 (2008), 23169–23178.
22. [22] Liu, P., Jamaluddin, M., Li, K., Garofalo, R.P., Casola, A., Brasier, A.R., Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol 81 (2007), 1401–1411.
23. [23] Yoboua, F., Martel, A., Duval, A., Mukawera, E., Grandvaux, N., Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta. J Virol 84 (2010), 7267–7277.
24. [24] Loo, Y.M., Fornek, J., Crochet, N., Bajwa, G., Perwitasari, O., Martinez-Sobrido, L., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82 (2008), 335–345.
25. [25] Yount, J.S., Gitlin, L., Moran, T.M., Lopez, C.B., MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J Immunol 180 (2008), 4910–4918.
26. [26] Banos-Lara Mdel, R., Ghosh, A., Guerrero-Plata, A., Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo. J Virol 87 (2013), 1242–1251.
27. [27] Gitlin, L., Benoit, L., Song, C., Cella, M., Gilfillan, S., Holtzman, M.J., et al. Melanoma differentiation-associated gene 5 (MDA5) is involved in the innate immune response to Paramyxoviridae infection in vivo. PLoS Pathog, 6, 2010, e1000734.
28. [28] Ikegame, S., Takeda, M., Ohno, S., Nakatsu, Y., Nakanishi, Y., Yanagi, Y., Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 84 (2010), 372–379.
29. [29] Kim, W.K., Jain, D., Sanchez, M.D., Koziol-White, C.J., Matthews, K., Ge, M.Q., et al. Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation. Am J Respir Crit Care Med 189 (2014), 437–448.
30. [30] Grandvaux, N., Guan, X., Yoboua, F., Zucchini, N., Fink, K., Doyon, P., et al. Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5. J Innate Immun 6 (2014), 650–662.
31. [31] Lifland, A.W., Jung, J., Alonas, E., Zurla, C., Crowe, J.E. Jr., Santangelo, P.J., Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol 86 (2012), 8245–8258.
32. [32] Murawski, M.R., Bowen, G.N., Cerny, A.M., Anderson, L.J., Haynes, L.M., Tripp, R.A., et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 83 (2009), 1492–1500.
33. [33] Rudd, B.D., Smit, J.J., Flavell, R.A., Alexopoulou, L., Schaller, M.A., Gruber, A., et al. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J Immunol 176 (2006), 1937–1942.
34. [34] Lukacs, N.W., Smit, J.J., Mukherjee, S., Morris, S.B., Nunez, G., Lindell, D.M., Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol 185 (2010), 2231–2239.
35. [35] Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1 (2000), 398–401.
36. [36] Mandelberg, A., Tal, G., Naugolny, L., Cesar, K., Oron, A., Houri, S., et al. Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncitial virus bronchiolitis. Clin Exp Immunol 144 (2006), 48–52.
37. [37] Tal, G., Mandelberg, A., Dalal, I., Cesar, K., Somekh, E., Tal, A., et al. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 189 (2004), 2057–2063.
38. [38] Marr, N., Turvey, S.E., Role of human TLR4 in respiratory syncytial virus-induced NF-kappaB activation, viral entry and replication. Innate Immun 18 (2012), 856–865.
39. [39] Paulus, S.C., Hirschfeld, A.F., Victor, R.E., Brunstein, J., Thomas, E., Turvey, S.E., Common human Toll-like receptor 4 polymorphisms–role in susceptibility to respiratory syncytial virus infection and functional immunological relevance. Clin Immunol 123 (2007), 252–257.
40. [40] Ehl, S., Bischoff, R., Ostler, T., Vallbracht, S., Schulte-Monting, J., Poltorak, A., et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 34 (2004), 1146–1153.
41. [41] Douville, R.N., Lissitsyn, Y., Hirschfeld, A.F., Becker, A.B., Kozyrskyj, A.L., Liem, J., et al. TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus. PLoS ONE, 5, 2010, e12087.
42. [42] Man, S.M., Kanneganti, T.D., Regulation of inflammasome activation. Immunol Rev 265 (2015), 6–21.
43. [43] Broz, P., Dixit, V.M., Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol 16 (2016), 407–420.
44. [44] Segovia, J., Sabbah, A., Mgbemena, V., Tsai, S.Y., Chang, T.H., Berton, M.T., et al. TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection. PLoS ONE, 7, 2012, e29695.
45. [45] Triantafilou, K., Kar, S., Vakakis, E., Kotecha, S., Triantafilou, M., Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax 68 (2013), 66–75.
46. [46] Sabbah, A., Chang, T.H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P.H., et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 10 (2009), 1073–1080.
47. [47] Wu, B., Hur, S., How RIG-I like receptors activate MAVS. Curr Opin Virol 12 (2015), 91–98.
48. [48] Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol 14 (2016), 360–373.
49. [49] McNab, F., Mayer-Barber, K., Sher, A., Wack, A., O'Garra, A., Type I interferons in infectious disease. Nat Rev Immunol 15 (2015), 87–103.
50. [50] Lazear, H.M., Nice, T.J., Diamond, M.S., Interferon-lambda: immune functions at barrier surfaces and beyond. Immunity 43 (2015), 15–28.
51. [51] Lopez, C.B., Hermesh, T., Systemic responses during local viral infections: type I IFNs sound the alarm. Curr Opin Immunol 23 (2011), 495–499.
52. [52] Goritzka, M., Durant, L.R., Pereira, C., Salek-Ardakani, S., Openshaw, P.J., Johansson, C., Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection. J Virol 88 (2014), 6128–6136.
53. [53] Rudd, B.D., Luker, G.D., Luker, K.E., Peebles, R.S., Lukacs, N.W., Type I interferon regulates respiratory virus infected dendritic cell maturation and cytokine production. Viral Immunol 20 (2007), 531–540.
54. [54] Goritzka, M., Makris, S., Kausar, F., Durant, L.R., Pereira, C., Kumagai, Y., et al. Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes. J Exp Med 212 (2015), 699–714.
55. [55] Durbin, J.E., Johnson, T.R., Durbin, R.K., Mertz, S.E., Morotti, R.A., Peebles, R.S., et al. The role of IFN in respiratory syncytial virus pathogenesis. J Immunol 168 (2002), 2944–2952.
56. [56] Cormier, S.A., Shrestha, B., Saravia, J., Lee, G.I., Shen, L., DeVincenzo, J.P., et al. Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection. J Virol 88 (2014), 9350–9360.
57. [57] Okabayashi, T., Kojima, T., Masaki, T., Yokota, S., Imaizumi, T., Tsutsumi, H., et al. Type-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cells. Virus Res 160 (2011), 360–366.
58. [58] Villenave, R., Broadbent, L., Douglas, I., Lyons, J.D., Coyle, P.V., Teng, M.N., et al. Induction and antagonism of antiviral responses in respiratory syncytial virus-infected pediatric airway epithelium. J Virol 89 (2015), 12309–12318.
59. [59] Ioannidis, I., Ye, F., McNally, B., Willette, M., Flano, E., Toll-like receptor expression and induction of type I and type III interferons in primary airway epithelial cells. J Virol 87 (2013), 3261–3270.
60. [60] Crotta, S., Davidson, S., Mahlakoiv, T., Desmet, C.J., Buckwalter, M.R., Albert, M.L., et al. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. PLoS Pathog, 9, 2013, e1003773.
61. [61] Barik, S., Respiratory syncytial virus mechanisms to interfere with type 1 interferons. Curr Top Microbiol Immunol 372 (2013), 173–191.
62. [62] Teng, M.N., Collins, P.L., Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein. J Virol 73 (1999), 466–473.
63. [63] Jin, H., Zhou, H., Cheng, X., Tang, R., Munoz, M., Nguyen, N., Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2–2 genes are attenuated in vitro and in vivo. Virology 273 (2000), 210–218.
64. [64] Spann, K.M., Tran, K.C., Chi, B., Rabin, R.L., Collins, P.L., Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [Corrected]. J Virol 78 (2004), 4363–4369.
65. [65] Swedan, S., Musiyenko, A., Barik, S., Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol 83 (2009), 9682–9693.
66. [66] Goswami, R., Majumdar, T., Dhar, J., Chattopadhyay, S., Bandyopadhyay, S.K., Verbovetskaya, V., et al. Viral degradasome hijacks mitochondria to suppress innate immunity. Cell Res 23 (2013), 1025–1042.
67. [67] Elliott, J., Lynch, O.T., Suessmuth, Y., Qian, P., Boyd, C.R., Burrows, J.F., et al. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol 81 (2007), 3428–3436.
68. [68] Ling, Z., Tran, K.C., Teng, M.N., Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. J Virol 83 (2009), 3734–3742.
69. [69] Cervantes-Ortiz, S.L., Zamorano Cuervo, N., Grandvaux, N., Respiratory syncytial virus and cellular stress responses: impact on replication and physiopathology. Viruses, 8, 2016.
70. [70] Bitko, V., Barik, S., An endoplasmic reticulum-specific stress-activated caspase (caspase-12) is implicated in the apoptosis of A549 epithelial cells by respiratory syncytial virus. J Cell Biochem 80 (2001), 441–454.
71. [71] Jheng, J.R., Ho, J.Y., Horng, J.T., ER stress, autophagy, and RNA viruses. Front Microbiol, 5, 2014, 388.
72. [72] Hassan, I., Gaines, K.S., Hottel, W.J., Wishy, R.M., Miller, S.E., Powers, L.S., et al. Inositol-requiring enzyme 1 inhibits respiratory syncytial virus replication. J Biol Chem 289 (2014), 7537–7546.
73. [73] Hollien, J., Lin, J.H., Li, H., Stevens, N., Walter, P., Weissman, J.S., Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol 186 (2009), 323–331.
74. [74] Darling, N.J., Cook, S.J., The role of MAPK signalling pathways in the response to endoplasmic reticulum stress. Biochim Biophys Acta 1843 (2014), 2150–2163.
75. [75] Lindquist, M.E., Lifland, A.W., Utley, T.J., Santangelo, P.J., Crowe, J.E. Jr., Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol 84 (2010), 12274–12284.
76. [76] Ng, C.S., Jogi, M., Yoo, J.S., Onomoto, K., Koike, S., Iwasaki, T., et al. Encephalomyocarditis virus disrupts stress granules, the critical platform for triggering antiviral innate immune responses. J Virol 87 (2013), 9511–9522.
77. [77] Fricke, J., Koo, L.Y., Brown, C.R., Collins, P.L., P38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly. J Virol 87 (2013), 1333–1347.
78. [78] Lindquist, M.E., Mainou, B.A., Dermody, T.S., Crowe, J.E. Jr., Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology 413 (2011), 103–110.
79. [79] Groskreutz, D.J., Babor, E.C., Monick, M.M., Varga, S.M., Hunninghake, G.W., Respiratory syncytial virus limits alpha subunit of eukaryotic translation initiation factor 2 (eIF2alpha) phosphorylation to maintain translation and viral replication. J Biol Chem 285 (2010), 24023–24031.
80. [80] Hanley, L.L., McGivern, D.R., Teng, M.N., Djang, R., Collins, P.L., Fearns, R., Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. Virology 406 (2010), 241–252.
81. [81] Garofalo, R.P., Kolli, D., Casola, A., Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal 18 (2013), 186–217.
82. [82] Fink, K., Duval, A., Martel, A., Soucy-Faulkner, A., Grandvaux, N., Dual role of NOX2 in respiratory syncytial virus- and sendai virus-induced activation of NF-kappaB in airway epithelial cells. J Immunol 180 (2008), 6911–6922.
83. [83] Soucy-Faulkner, A., Mukawera, E., Fink, K., Martel, A., Jouan, L., Nzengue, Y., et al. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog, 6, 2010, e1000930.
84. [84] Indukuri, H., Castro, S.M., Liao, S.M., Feeney, L.A., Dorsch, M., Coyle, A.J., et al. Ikkepsilon regulates viral-induced interferon regulatory factor-3 activation via a redox-sensitive pathway. Virology 353 (2006), 155–165.
85. [85] Fink, K., Martin, L., Mukawera, E., Chartier, S., De Deken, X., Brochiero, E., et al. IFNbeta/TNFalpha synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. Cell Res 23 (2013), 673–690.
86. [86] Mgbemena, V., Segovia, J., Chang, T.H., Bose, S., KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection. Cell Immunol 283 (2013), 1–7.
87. [87] Kotelkin, A., Prikhod'ko, E.A., Cohen, J.I., Collins, P.L., Bukreyev, A., Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Virol 77 (2003), 9156–9172.
88. [88] Nakamura-Lopez, Y., Villegas-Sepulveda, N., Gomez, B., RSV P-protein impairs extrinsic apoptosis pathway in a macrophage-like cell line persistently infected with respiratory syncytial virus. Virus Res 204 (2015), 82–87.
89. [89] Taylor, G., Wyld, S., Valarcher, J.F., Guzman, E., Thom, M., Widdison, S., et al. Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. J Gen Virol 95 (2014), 1244–1254.
90. [90] Fuentes, S., Tran, K.C., Luthra, P., Teng, M.N., He, B., Function of the respiratory syncytial virus small hydrophobic protein. J Virol 81 (2007), 8361–8366.
91. [91] Bitko, V., Shulyayeva, O., Mazumder, B., Musiyenko, A., Ramaswamy, M., Look, D.C., et al. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol 81 (2007), 1786–1795.
92. [92] Li, Y., Jain, N., Limpanawat, S., To, J., Quistgaard, E.M., Nordlund, P., et al. Interaction between human BAP31 and respiratory syncytial virus small hydrophobic (SH) protein. Virology 482 (2015), 105–110.
93. [93] Othumpangat, S., Walton, C., Piedimonte, G., MicroRNA-221 modulates RSV replication in human bronchial epithelium by targeting NGF expression. PLoS ONE, 7, 2012, e30030.
94. [94] Pathak, K.B., Nagy, P.D., Defective interfering RNAs: foes of viruses and friends of virologists. Viruses 1 (2009), 895–919.
95. [95] Tapia, K., Kim, W.K., Sun, Y., Mercado-Lopez, X., Dunay, E., Wise, M., et al. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity. PLoS Pathog, 9, 2013, e1003703.
96. [96] Yount, J.S., Kraus, T.A., Horvath, C.M., Moran, T.M., Lopez, C.B., A novel role for viral-defective interfering particles in enhancing dendritic cell maturation. J Immunol 177 (2006), 4503–4513.
97. [97] Xu, J., Mercado-Lopez, X., Grier, J.T., Kim, W.K., Chun, L.F., Irvine, E.B., et al. Identification of a natural viral RNA motif that optimizes sensing of viral RNA by RIG-I. MBio 6 (2015), e01265–15.
98. [98] Treuhaft, M.W., Beem, M.O., Defective interfering particles of respiratory syncytial virus. Infect Immun 37 (1982), 439–444.
99. [99] Sarmiento, R.E., Tirado, R., Gomez, B., Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture. Virus Res 84 (2002), 45–58.
100. [100] Valdovinos, M.R., Gomez, B., Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles. Intervirology 46 (2003), 190–198.